Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health.
Vanier A, Fernandez J, Kelley S, Alter L, Semenzato P, Alberti C, Chevret S, Costagliola D, Cucherat M, Falissard B, Gueyffier F, Lambert J, Lengliné E, Locher C, Naudet F, Porcher R, Thiébaut R, Vray M, Zohar S, Cochat P, Le Guludec D.
Vanier A, et al. Among authors: locher c.
BMJ Evid Based Med. 2024 Jan 19;29(1):1-5. doi: 10.1136/bmjebm-2022-112091.
BMJ Evid Based Med. 2024.
PMID: 36788020
Free PMC article.
No abstract available.